Research and Markets: Batten Disease - Pipeline Review, H1 2014 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/69tgww/batten_disease) has announced the addition of the "Batten Disease - Pipeline Review, H1 2014" report to their offering.

'Batten Disease - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Batten Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Batten Disease.

Batten Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Scope

- A snapshot of the global therapeutic scenario for Batten Disease.

- A review of the Batten Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Batten Disease pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Batten Disease Overview

Therapeutics Development

Clinical Stage Products

Early Stage Products

Batten Disease - Products under Development by Companies

Batten Disease - Products under Investigation by Universities/Institutes

Batten Disease - Companies Involved in Therapeutics Development

Batten Disease - Therapeutics Assessment

Drug Profiles

cysteamine + [acetylcysteine] - Drug Profile

BMN-190 - Drug Profile

Gene Therapy To Activate Tripeptidyl Peptidase 1 For Batten Disease - Drug Profile

Gene Therapy + Bone Marrow Transplantation - Drug Profile

Batten Disease Program - Drug Profile

Featured News & Press Releases

Appendix

Companies Mentioned

BioMarin Pharmaceutical Inc.

ReGenX Biosciences, LLC

Seneb BioSciences, Inc.

For more information visit http://www.researchandmarkets.com/research/69tgww/batten_disease

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System